Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva

View ORCID ProfileIsao Yokota, Takayo Sakurazawa, View ORCID ProfileJunichi Sugita, Sumio Iwasaki, Keiko Yasuda, Naoki Yamashita, Shinichi Fujisawa, View ORCID ProfileMutsumi Nishida, View ORCID ProfileSatoshi Konno, View ORCID ProfileTakanori Teshima
doi: https://doi.org/10.1101/2020.11.06.20227363
Isao Yokota
1Department of Biostatistics, Hokkaido University Faculty of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Isao Yokota
Takayo Sakurazawa
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junichi Sugita
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Junichi Sugita
Sumio Iwasaki
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keiko Yasuda
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoki Yamashita
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinichi Fujisawa
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mutsumi Nishida
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mutsumi Nishida
Satoshi Konno
3Department of Respiratory Medicine, Hokkaido University Faculty of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Satoshi Konno
Takanori Teshima
2Division of Laboratory and Transfusion Medicine, Hokkaido University Hospital, Sapporo, Japan
4Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Takanori Teshima
  • For correspondence: teshima@med.hokudai.ac.jp
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The rapid detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an urgent need for the prevention and containment of disease outbreaks in communities. Although the gold standard is polymerase chain reaction (PCR), antigen tests such as immunochromatographic assay (ICA) and chemiluminescent enzyme immunoassay (CLEIA) that can yield results within 30 minutes.

Methods We evaluated performance of ICA and CLEIA using 34 frozen PCR-positive specimens (17 saliva and 17 nasopharyngeal swab) and 307 PCR-negative samples.

Results ICA detected SARS-CoV-2 in only 14 (41%) samples, with positivity of 24% in saliva and 59% in NPS. Notably, ICA detected SARS-CoV-2 in 5 (83%) of 6 samples collected within 4 days after symptom onset. CLEIA detected SARS-CoV-2 in 31 (91%) samples, with positivity of 82% in saliva and 100% in NPS. CLEIA was negative in 3 samples with low viral load by PCR.

Conclusions These results suggest that use of ICA should be limited to earlier time after symptom onset and CLEIA is more sensitive and can be used in situations where quick results are required.

  • SARS-CoV-2
  • COVID-19
  • Antigen test
  • Chemiluminescent enzyme immunoassay
  • Lumipulse
  • Espline

Competing Interest Statement

Espline SARS-CoV-2 and Lumipulse SARS-CoV-2 Ag kit were supplied by Fujirebio.

Funding Statement

This study was supported by Health, Labour and Welfare Policy Research Grants 20HA2002.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Institutional Ethics Board (Hokkaido University Hospital Division of Clinical Research Administration Number: 020-0116).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data are included in Supplements.

  • List of abbreviations

    SARS-CoV-2
    severe acute respiratory syndrome coronavirus 2
    PCR
    polymerase chain reaction
    LAMP
    loop-medicated isothermal amplification
    ICA
    immunochromatographic assay
    CLEIA
    chemiluminescent enzyme immunoassay
    COVID-19
    coronavirus disease-19
    NPS
    nasopharyngeal swab samples
    NAAT
    nucleic acid amplification test
    NIID
    National Institute of Infectious Diseases
    CI
    confidential interval
    Tp
    time for detecting positive results
    IQR
    interquartile range
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted November 10, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva
    Isao Yokota, Takayo Sakurazawa, Junichi Sugita, Sumio Iwasaki, Keiko Yasuda, Naoki Yamashita, Shinichi Fujisawa, Mutsumi Nishida, Satoshi Konno, Takanori Teshima
    medRxiv 2020.11.06.20227363; doi: https://doi.org/10.1101/2020.11.06.20227363
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    Performance of qualitative and quantitative antigen tests for SARS-CoV-2 in early symptomatic patients using saliva
    Isao Yokota, Takayo Sakurazawa, Junichi Sugita, Sumio Iwasaki, Keiko Yasuda, Naoki Yamashita, Shinichi Fujisawa, Mutsumi Nishida, Satoshi Konno, Takanori Teshima
    medRxiv 2020.11.06.20227363; doi: https://doi.org/10.1101/2020.11.06.20227363

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Infectious Diseases (except HIV/AIDS)
    Subject Areas
    All Articles
    • Addiction Medicine (70)
    • Allergy and Immunology (168)
    • Anesthesia (49)
    • Cardiovascular Medicine (448)
    • Dentistry and Oral Medicine (80)
    • Dermatology (55)
    • Emergency Medicine (157)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
    • Epidemiology (5216)
    • Forensic Medicine (3)
    • Gastroenterology (194)
    • Genetic and Genomic Medicine (750)
    • Geriatric Medicine (77)
    • Health Economics (212)
    • Health Informatics (694)
    • Health Policy (352)
    • Health Systems and Quality Improvement (223)
    • Hematology (98)
    • HIV/AIDS (162)
    • Infectious Diseases (except HIV/AIDS) (5816)
    • Intensive Care and Critical Care Medicine (356)
    • Medical Education (102)
    • Medical Ethics (25)
    • Nephrology (80)
    • Neurology (758)
    • Nursing (43)
    • Nutrition (129)
    • Obstetrics and Gynecology (141)
    • Occupational and Environmental Health (231)
    • Oncology (475)
    • Ophthalmology (149)
    • Orthopedics (38)
    • Otolaryngology (93)
    • Pain Medicine (39)
    • Palliative Medicine (19)
    • Pathology (139)
    • Pediatrics (223)
    • Pharmacology and Therapeutics (136)
    • Primary Care Research (96)
    • Psychiatry and Clinical Psychology (854)
    • Public and Global Health (1993)
    • Radiology and Imaging (344)
    • Rehabilitation Medicine and Physical Therapy (157)
    • Respiratory Medicine (283)
    • Rheumatology (93)
    • Sexual and Reproductive Health (72)
    • Sports Medicine (75)
    • Surgery (108)
    • Toxicology (25)
    • Transplantation (29)
    • Urology (39)